VTRS (Viatris Inc.) Stock Financials & Earnings

VTRSViatris Inc.

Mkt Cap$17B

Revenue (TTM)$14.3B

Net Income (TTM)-$3.5B

EPS (TTM)-$2.96

Free Cash Flow (TTM)$1.8B

Gross Margin35.1%

Op. Margin-18.6%

Net Margin-24.6%

FCF Margin12.7%

P/S Ratio (TTM)1.2x

P/E Ratio (TTM)—

YoY Rev Growth-3.0%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$3.7B	$1.5B	$400M
Q2 23	$3.9B	$1.6B	$369M
Q3 23	$3.9B	$1.7B	$452M
Q4 23	$3.8B	$1.6B	-$455M
Q1 24	$3.7B	$1.5B	$204M
Q2 24	$3.8B	$1.4B	-$240M
Q3 24	$3.8B	$1.5B	$226M
Q4 24	$3.5B	$1.2B	-$180M
Q1 25	$3.3B	$1.2B	-$2.9B
Q2 25	$3.6B	$1.3B	$233M
Q3 25	$3.8B	$1.4B	$252M
Q4 25	$3.7B	$1.1B	-$266M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Quarter	Brands	Complex GX and Biosimilars	Generics
Q1 23	$2.4B	$136M	$1.2B
Q2 23	$2.4B	$139M	$1.3B
Q3 23	$2.5B	$174M	$1.2B
Q1 24	$2.3B	—	$1.3B
Q2 24	$2.4B	—	$1.4B
Q3 24	$2.4B	—	$1.4B
Q1 25	$2.1B	—	$1.1B
Q2 25	$2.3B	—	$1.3B
Q3 25	$2.4B	—	$1.3B
Q4 25	$2.3B	—	$1.3B

Revenue by Geography

Quarter	Developed Markets Segment	Emerging Markets Segment	Greater China Segment	Japan, Australia and New Zealand Segment
Q1 23	$2.2B	$642M	$565M	$342M
Q2 23	$2.4B	$648M	$532M	$376M
Q3 23	$2.4B	$643M	$548M	$335M
Q4 23	$2.3B	$619M	$515M	$372M
Q1 24	$2.2B	$626M	$544M	$318M
Q2 24	$2.3B	$578M	$539M	$350M
Q3 24	$2.3B	$533M	$562M	$344M
Q4 24	$2.2B	$523M	$523M	$338M
Q1 25	$1.9B	$523M	$556M	$277M
Q2 25	$2.1B	$557M	$589M	$307M
Q3 25	$2.3B	$572M	$615M	$307M
Q4 25	$2.3B	$566M	$573M	$307M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$507M	$174M	$680M
Q2 23	$629M	$177M	$806M
Q3 23	$1.3B	$255M	$1.6B
Q4 23	$992M	$193M	$1.2B
Q1 24	$1.0B	$164M	$1.2B
Q2 24	$917M	$225M	$1.1B
Q3 24	$1.9B	$169M	$2.0B
Q4 24	$735M	$355M	$1.1B
Q1 25	$755M	$247M	$1.0B
Q2 25	$566M	$242M	$809M
Q3 25	$975M	$182M	$1.2B
Q4 25	$1.3B	$106M	$1.5B

Shares Outstanding

Revenue Per Employee

Revenue / Employee